Texas A&M Football

Cover Story: Ags are exhibiting passion, physicality & poise in SEC start

Just three weeks after a disappointing early-season setback at Miami, Jimbo Fisher's Aggies are exhibiting passion, physicality and poise in starting 2-0 in conference play. With Alabama coming to town, Texas A&M's formula must continue to extend a modest winning streak.
By Billy Liucci
October 2, 2023
9.2k Views
Discuss
Story Poster
Photo by Jerome Miron-USA TODAY Sports

Just three weeks ago, Texas A&M faced its first test of a highly-anticipated and vitally-important season.

The Ags traveled to Miami and (after a hot start) fell to the Hurricanes in a manner that exposed more weaknesses than expected.

Long story short: Texas A&M looked like anything but an SEC title contender.

Coming back from South Florida, one of the few answers Jimbo Fisher had was that he finally had a top-tier quarterback.

To continue reading, you must be a TexAgs Premium subscriber.
Get Premium for $1
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial
Discuss
Tags
Bobby Petrino D.J. Durkin Kirby Smart Nick Saban Cover Story Jimbo Fisher Will Rogers KJ Jefferson Jaxson Dart Tyler Van Dyke Raheim Sanders Jalen Milroe
Show All
Tommy Rees Lorando Johnson Texas A&M at Miami Texas A&M vs. Auburn Texas A&M vs. Arkansas Texas A&M vs. Alabama Demani Richardson Bryce Foster Ainias Smith Max Johnson Conner Weigman Tyreek Chappell Le'Veon Moss Evan Stewart Football Texas A&M Arkansas LSU Georgia Auburn Miami Alabama 2023
SPONSORED BY
Yeti
More Football
See All →
A&M expects Mizzou's offense to be tailored differently around Zollers
By Olin Buchanan
Press Conference: No. 3 Aggies travel to face No. 19 Mizzou in CoMo
By TexAgs
Live Press Conference Notes: Elko & Co. return to action at Mizzou
By Kay Naegeli
No Layups CFB: Hoosier grad Connor O'Gara on Indiana's perception & more
By David Nuño
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.